Efficacy of sodium–glucose cotransporter 2 inhibitors and angiotensin <scp>receptor–neprilysin</scp> inhibitors for heart failure in black patients: a systematic review and <scp>meta‐analysis</scp> of randomized controlled trials-Reference-Cited by-同舟云学术

Efficacy of sodium–glucose cotransporter 2 inhibitors and angiotensin receptor–neprilysin inhibitors for heart failure in black patients: a systematic review and meta‐analysis of randomized controlled trials

Published:2023-03-15 Issue:4 Volume:25 Page:591-593
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Pandey Arjun K.¹^ORCID,Dhingra Nitish K.²,Pandey Avinash³,Puar Pankaj⁴,Ahmed Shamon⁴,Verma Raj⁵,Mazer C. David⁶,Butler Javed⁷⁸,Badiwala Mitesh⁹,Yau Terrence M.⁹,Yanagawa Bobby⁹,Bhatt Deepak L.¹⁰,Verma Subodh⁹

Affiliation:

1. Michael G. DeGroote School of Medicine McMaster University Hamilton ON Canada

2. Temetry Faculty of Medicine University of Toronto Toronto ON Canada

3. Faculty of Medicine University of Ottawa Ottawa ON Canada

4. Faculty of Medicine University of British Columbia Vancouver BC Canada

5. School of Medicine Royal College of Surgeons Dublin 2 Ireland

6. Department of Anesthesiology and Pain Medicine University of Toronto Toronto ON Canada

7. Baylor Scott and White Research Institute Dallas TX USA

8. University of Mississippi Jackson MS USA

9. Division of Cardiovascular Surgery, Department of Surgery University of Toronto Toronto ON Canada

10. Mount Sinai Heart Icahn School of Medicine at Mount Sinai Health System New York City NY USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2825

Reference22 articles.

1. Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients

2. Recruitment of Black Adults into Cardiovascular Disease Trials

3. Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure

4. Race Influences the Safety and Efficacy of Spironolactone in Severe Heart Failure

5. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status